| 1 | 4.5 mg naltrexone | Naltrexone | 2件: D02095D02095, D05113D05113 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0131件: 13 💬 | 
| 2 | Low dose naltrexone | Naltrexone | 2件: D02095D02095, D05113D05113 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0962件: 96, 97 💬 | 
| 3 | Low-dose naltrexone | Naltrexone | 2件: D02095D02095, D05113D05113 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 4 | Nal | - | - | - | - | 0062件:  6 , 299 💬 | 
| 5 | Nalbuphine | Nalbuphine | 2件: D00843D00843, D08246D08246 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0851件: 85 💬 | 
| 6 | Nalbuphine er | Nalbuphine | 2件: D00843D00843, D08246D08246 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0851件: 85 💬 | 
| 7 | Nalbuphine extended-realease (er) tablets | Nalbuphine | 2件: D00843D00843, D08246D08246 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0851件: 85 💬 | 
| 8 | Nalbuphine extended-release (er) tablets | Nalbuphine | 2件: D00843D00843, D08246D08246 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0851件: 85 💬 | 
| 9 | Nalbuphine hydrochloride | Nalbuphine | 2件: D00843D00843, D08246D08246 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0851件: 85 💬 | 
| 10 | Nalmefene | Nalmefene | 1件: D05111D05111 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 11 | Naloxone | Naloxone | 2件: D01340D01340, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0062件:  6 , 226 💬 | 
| 12 | Naloxone hydrochloride | Naloxone | 2件: D01340D01340, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 13 | Naloxone hydrochloride dihydrate | Naloxone | 2件: D01340D01340, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 14 | Naltrexone | Naltrexone | 2件: D02095D02095, D05113D05113 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 00612件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 | 
| 15 | Naltrexone hydrochloride | Naltrexone | 2件: D02095D02095, D05113D05113 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0108件: 10, 40, 41, 42, 43, 44, 45, 96 💬 | 
| 16 | Naltrexone-hcl | Naltrexone | 2件: D02095D02095, D05113D05113 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0961件: 96 💬 | 
| 17 | Oxycodone naloxone prolonged release tablets | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 18 | Oxycodone/naloxone prolonged release t | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 19 | Oxycodone/naloxone prolonged release tablets | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 20 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 21 | Oxycodone/naloxone prolonged release tablets 10/5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 22 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 23 | Oxycodone/naloxone prolonged release tablets 20/10 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 24 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 25 | Oxycodone/naloxone prolonged release tablets 5/2.5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 |